ROCHESTER, N.Y.--(BUSINESS WIRE)--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, appointed Bonnie Labosky, a former Medtronic Vice President and General Manager of the Heart Failure Division, to its Board of Directors. Ms. Labosky ran Medtronic’s Heart Failure division, which today is a $1.6 billion product category for the medical device company, and one in which it holds a 50% market share.
